Abstract
African animal trypanosomosis poses a significant threat to livestock health and agricultural productivity across sub-Saharan Africa. Isometamidium chloride is the only available drug that is both prophylactic and curative. Despite sustained reports of resistance since the 1970s, a definitive molecular mechanism of resistance remains unresolved in the clinically relevant pathogen species Trypanosoma congolense. In this study, the role of a putative drug/metabolite transporter protein, TcoDMT, was validated via the analysis of in vitro-derived mutants, showing that expression levels of this protein correlated strongly with isometamidium sensitivity. Functional analyses revealed that the protein is a cell surface phenanthridine transporter and, notably, copy number variation correlates with Isometamidium sensitivity in T. congolense field isolates. This study validates, for the first time, a plasma membrane transporter with a defined role in phenanthridine action and resistance, advancing our understanding of drug resistance mechanisms in parasitic protists, and informing strategies to combat animal trypanosomosis.
| Original language | English |
|---|---|
| Publisher | Research Square |
| Number of pages | 29 |
| DOIs | |
| Publication status | Published - 17-Feb-2026 |
Keywords
- Phenanthridine
- Transporter
- Drug resistance
- Trypanocidal agent
- ATP-binding cassette transporter
- Transport protein
- Membrane transport protein
- Virulence
- Cell membrane
- Trypanosoma evansi
Fingerprint
Dive into the research topics of 'A cell surface transporter mediates phenanthridine resistance in African trypanosomes'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver